ARTICLE | Company News
Teva autoimmune, neurology, biosimilars news
August 20, 2012 7:00 AM UTC
Teva said that on July 9 it received a subpoena from the SEC to produce documents related to compliance with the Foreign Corrupt Practices Act (FCPA) in Latin America. The FCPA makes it unlawful to br...